FDA Inspection 1231122 — Coriell Institue For Medical Research

Coriell Institue For Medical Research — FEI 3006403223

The FDA completed an inspection of Coriell Institue For Medical Research on Feb 12, 2024 in Camden, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 12, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Camden, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.